Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Emory University
With
Novo Nordisk A/S
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Males or females between the ages of 18 and 70 years admitted to a general medical service.
2. A known history of type 2 diabetes mellitus \> 3 months, receiving any combination of oral antidiabetic agents (sulfonylureas, metformin, thiazolidinediones) and/or insulin therapy.
3. Subjects must have an admission blood glucose \> 140 mg and \< 400 mg/dL and no evidence of ketoacidosis (serum bicarbonate \< 18 mEq/L, venous or arterial pH \< 7.30, positive serum or urinary ketones).
You may not be if
1. Subjects with increased blood glucose concentration, but without a known history of diabetes.
2. Subjects with a history of acute hyperglycemic crises such as diabetic ketoacidosis and hyperosmolar hyperglycemic state, or ketonuria \[63\].
3. Patients with acute critical or surgical illness and/or expected to require admission to a critical care unit (ICU, CCU), or to undergo surgery during the hospitalization course.
4. Patients with clinically relevant hepatic disease (ALT 2.5x \> upper limit of normal), or impaired renal function, as shown by a serum creatinine ≥2.0 mg/dL for males, or ≥ 1.8 mg/dL for females.
5. History of drug or alcohol abuse within the last 2 years.
6. Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
7. Patients with recognized or suspected endocrine disorders associated with increased insulin resistance, such as hypercortisolism, acromegaly, or hyperthyroidism.
8. Female subjects are pregnant or breast feeding at time of enrollment into the study.
Clareo Health | Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
